Patents by Inventor Michael W. McGowan

Michael W. McGowan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Determination of HDL whole blood
    Patent number: 5118613
    Abstract: A method for separating HDL from whole blood anticoagulated with EDTA is disclosed. The method includes, as a first step, mixing the anticoagulated whole blood with an aqueous solution composed of magnesium .sup.++ cations and dextran sulfate 500 in such proportions and of such concentration(a) that substantially all of the LDL and VLDL lipoproteins and substantially all of the chylomicrons are precipitated while(b) substantially all of the HDL remains in solution.The method also includes the step of sedimenting the precipitated lipoproteins, the chylomicrons and the red blood cells by centrifuging, which can be low gravity centrifuging, and can include the step of determining the cholesterol, triglyceride, phospholipid or protein content of the supernatant.
    Type: Grant
    Filed: November 17, 1989
    Date of Patent: June 2, 1992
    Assignee: Abbott Laboratories
    Inventor: Michael W. McGowan
  • Container for use with an automatic analyzer
    Patent number: D439345
    Type: Grant
    Filed: May 22, 1997
    Date of Patent: March 20, 2001
    Assignee: Abbott Laboratories
    Inventors: Steve Herchenbach, Linas P. Laurusonis, Michael W. McGowan, Scott G. Safar
  • Container for use with an automatic analyzer
    Patent number: D401699
    Type: Grant
    Filed: May 22, 1997
    Date of Patent: November 24, 1998
    Assignee: Abbott Laboratories
    Inventors: Steve Herchenbach, Linas P. Laurusonis, Michael W. McGowan, Scott G. Safar